Institutional
Shareholder Services recommended that DepoMed Inc. (Nasdaq: DEPO) hold a
special shareholder meeting to consider Horizon Pharma's (Nasdaq: HZNP)
acquisition offer. Shares of DepoMed leaped $3.35 to close at $18.85 while Horizon Pharma stock surged $3.01 to close at $19.82.
DepoMed urged to consider Horizon Pharma offer
September 30, 2015 at 18:34 PM EDT